DAPK1 and non-small cell lung carcinoma: On the basis of lung cancer patient samples, hypermethylation of DAPK1 was detected in 39% of cancerous tissues; additionally, high levels of hypermethylation of DAPK1 were also found in 33% of NSCLC tissues.126